Skip to content
Menu
  • Press Releases
  • News
  • Industries
    • Agriculture
    • Automotive
    • Chemical and material
    • Consumer goods
    • Energy and power
    • Food and beverages
    • Healthcare
    • Information And Communication Technology
    • Machinery and equipment
    • Packaging
    • Semiconductor and electronic
    • Uncategorized
  • About Us
  • Contact Us
Menu
Decongestant Market

Increasing Focus on Nasal Congestion Relief Drives Decongestant Market Trends

Posted on August 22, 2024August 22, 2024 by Anuja Desai

The decongestant market comprises oral and nasal decongestant medications that help provide relief from nasal congestion associated with common cold, allergies, and sinusitis. Decongestants work by constricting blood vessels in the nasal passages to reduce swelling and mucus production, allowing better breathing through clearer nasal pathways. The global decongestant market is becoming increasingly popular due to its effectiveness and convenience of use at home for fast relief from congested nose and related symptoms.

The Global Decongestant Market is estimated to be valued at US$ 17.88 Bn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the decongestant market are Johnson and Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc, Prestige Consumer Healthcare Inc., Procter and Gamble Co., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Perrigo Company plc, Church and Dwight Co., Inc., Mylan N.V. Marinomed Biotech AG, Dr. Reddy’s Laboratories Ltd. The growing prevalence of nasal congestion disorders such as common cold, sinusitis, allergic rhinitis globally is expected to drive the demand for decongestant products. The manufacturers are also focusing on geographical expansion and product development to cater to unmet needs and capture untapped markets.

The Decongestant Market Trends is witnessing high growth owing to increasing instances of nasal congestion worldwide. As per estimates, over 1 billion common cold cases are reported annually in the United States alone. With sedentary lifestyle and long working hours prevalent, the risk of developing allergies and sinus issues is rising. This is creating significant demand for effective decongestants for quick relief from nasal blockage and related symptoms.

The global manufacturers are focusing on geographic expansion into emerging markets of Asia Pacific, Latin America, and Middle East & Africa. These regions are expected to witness highest growth in the decongestant market during the forecast period. The increasing disposable incomes and growing awareness about decongestants are supporting this expansion. Several private label brands have also entered these regions, making effective decongestants more accessible and affordable.

Market Key Trends

Development of extended-release formulations is a key trend gaining traction in the Decongestant Market Size And Trends Unlike conventional decongestants that provide only temporary relief, extended-release drugs maintain therapeutic drug levels for longer to provide whole-day congestion relief with single dose. Their widespread adoption is expected to drive future market gains. Also, manufacturers are focusing on combination products targeting multiple symptoms. For instance, combining decongestants with antihistamines, expectorants or painkillers in single pills can offer comprehensive relief for cold, allergies and flu.

Porter’s Analysis

Threat of new entrants: New players can enter the decongestant market easily as the investment required is moderately low but established brands have significant brand loyalty.

Bargaining power of buyers: Buyers have moderate bargaining power as there are many established brands in the market but switching costs are also low.

Bargaining power of suppliers: A few major players dominate the supply side so suppliers have moderate bargaining power.

Threat of new substitutes: There exist product substitutes like antihistamines but customer preferences for decongestants remain strong.

Competitive rivalry: The market is highly fragmented with the presence of many global as well as local suppliers.

Geographical regions: North America accounts for the largest share of the global decongestant market currently as nasal congestion is highly prevalent.

The Asia Pacific region is expected to witness the fastest growth during the forecast period due to increasing healthcare expenditure, large patient population and rapid urbanization in many countries of the region.

*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it

About us

Welcome to DailyPRBulletin.com, your ultimate source for the latest news, insightful articles, and impactful press releases across diverse industries! We are a team of passionate journalists, writers, and industry experts committed to keeping you informed, enlightened, and engaged with the rapidly evolving world of information.

©2025 | Design: Newspaperly WordPress Theme